{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:21:01Z","timestamp":1792412461599,"version":"4.4.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cryopyrin-associated periodic syndrome (CAPS) is a rare but treatable inherited autoinflammatory condition including familial cold autoinflammatory syndrome (FCAS), Muckle\u2013Wells syndrome (MWS) and chronic infantile neurologic cutaneous articular syndrome (CINCA). Our objective was to describe the main features of CAPS AA amyloidosis (AA-CAPS) associated and the efficacy of IL-1 inhibitors in this indication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective study in France associated with a systematic literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-six patients were identified: 23 new French cases and 63 from the literature, with a median age at amyloidosis diagnosis of 39\u2009years old. CAPS subtypes were MWS (n\u2009=\u200962), FCAS (n\u2009=\u20099), frontier forms between MWS and FCAS (n\u2009=\u200912) and between CINCA and MWS (n\u2009=\u20093). NLRP3 had been sequenced in 60 patients (70%) and the most frequent mutation was R260W (60%). Three AA-CAPS patients displayed somatic NLRP3 mutations. Death occurred in 35 patients (41%), none of whom having ever received IL-1 inhibitors. Twenty-eight patients (33%) received IL-1 inhibitors, with a &amp;gt;50% decrease in proteinuria in 89% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AA amyloidosis can occur in nearly all CAPS subtypes. IL-1 inhibitors are effective, underlining the necessity of an early diagnosis of CAPS in order to start this treatment as soon as possible among AA-CAPS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac145","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T15:12:03Z","timestamp":1646752323000},"page":"4827-4834","source":"Crossref","is-referenced-by-count":20,"title":["AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review"],"prefix":"10.1093","volume":"61","author":[{"given":"Fran\u00e7ois","family":"Rodrigues","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Sorbonne Universit\u00e9, H\u00f4pital Tenon, Assistance Publique-H\u00f4pitaux de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Cuisset","sequence":"additional","affiliation":[{"name":"Department of Genetics, Cochin Hospital, Universit\u00e9 de Paris , Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re","family":"Cador-Rousseau","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre Hospitalier Universitaire Pontchaillou , Rennes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Giurgea","sequence":"additional","affiliation":[{"name":"D\u00e9partement de G\u00e9n\u00e9tique M\u00e9dicale, Sorbonne Universit\u00e9, INSERM Childhood Genetic Diseases, AP-HP. H\u00f4pital Trousseau"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Neven","sequence":"additional","affiliation":[{"name":"Department of Rheumatologic Pediatry, Necker Hospital, Universit\u00e9 de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Buob","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sorbonne Universit\u00e9, H\u00f4pital Tenon, Assistance Publique-H\u00f4pitaux de Paris , Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-549X","authenticated-orcid":false,"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[{"name":"Department of Rheumatologic Pediatry, Necker Hospital, Universit\u00e9 de Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, Service de M\u00e9decine Interne et Immunologie Clinique, Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes Syst\u00e9miques Rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE\u2014Institute for Translational Research in Inflammation , Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lequerr\u00e9","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & CIC-CRB1404, INSERM, U1234, Normandie University, Rouen University Hospital , Rouen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Cam","sequence":"additional","affiliation":[{"name":"Service de n\u00e9phrologie, Centre hospitalier de Saint-Malo, Saint-Malo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilaine","family":"Boursier","sequence":"additional","affiliation":[{"name":"Laboratory of Rare and Autoinflammatory Genetic Diseases and Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), CHU Montpellier, University of Montpellier , Montpellier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Hervieu","sequence":"additional","affiliation":[{"name":"Pathology Department, Hopital Edouard Herriot , Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Sorbonne Universit\u00e9, H\u00f4pital Tenon, Assistance Publique-H\u00f4pitaux de Paris"},{"name":"Groupe de recherche clinique amylose AA (GRC AA SU) , Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Sorbonne Universit\u00e9, H\u00f4pital Tenon, Assistance Publique-H\u00f4pitaux de Paris"},{"name":"Groupe de recherche clinique amylose AA (GRC AA SU) , Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"2022112912434559900_keac145-B1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ncprheum0874","article-title":"Cryopyrinopathies: update on pathogenesis and treatment","volume":"4","author":"Neven","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2022112912434559900_keac145-B2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/art.22491","article-title":"The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model","volume":"56","author":"Aksentijevich","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022112912434559900_keac145-B3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022112912434559900_keac145-B4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2019.11.035","article-title":"NLRP3-associated autoinflammatory diseases: phenotypic and molecular characteristics of germline versus somatic mutations","volume":"145","author":"Louvrier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2022112912434559900_keac145-B5","first-page":"235","article-title":"Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome","volume":"31","author":"Muckle","year":"1962","journal-title":"Q J Med"},{"key":"2022112912434559900_keac145-B6","first-page":"w13580","article-title":"AA amyloidosis: basic knowledge, unmet needs and future treatments","volume":"142","author":"Obici","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"2022112912434559900_keac145-B7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022112912434559900_keac145-B8","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"2022112912434559900_keac145-B9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022112912434559900_keac145-B10","author":"Kon\u00e9-Paut","year":"2022"},{"key":"2022112912434559900_keac145-B11","first-page":"982","article-title":"Corr\u00e9lations ph\u00e9notype-g\u00e9notype au sein d\u2019une famille atteinte du syndrome de Muckle-Wells avec \u00e9vidence d\u2019une h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 clinique. Proceedings of the 22nd Congress of the French Society of Rheumatology; 2009 Nov 29 \u2013 Dec 2; La D\u00e9fense, Paris. 1","volume":"76","author":"Piram","year":"2009","journal-title":"Joint Bone Spine"},{"key":"2022112912434559900_keac145-B12","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/art.10944","article-title":"The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever","volume":"48","author":"Gershoni-Baruch","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2022112912434559900_keac145-B13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/10408363.2018.1488805","article-title":"Mosaicism in autoinflammatory diseases: cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review","volume":"55","author":"Labrousse","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2022112912434559900_keac145-B14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"Ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022112912434559900_keac145-B15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jbspin.2010.04.018","article-title":"Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome","volume":"77","author":"A\u00eft-Abdesselam","year":"2010","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"2022112912434559900_keac145-B16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/ijn.IJN_190_19","article-title":"A case of hearing impairment with renal dysfunction","volume":"31","author":"Prakash","year":"2021","journal-title":"Indian J Nephrol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac145\/43139176\/keac145.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4827\/47385994\/keac145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4827\/47385994\/keac145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:46:01Z","timestamp":1669707961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/12\/4827\/6545281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,3,9]]},"published-print":{"date-parts":[[2022,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac145","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,3,9]]}}}